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Abstract 
The application of conventional organic solvents is essential in several steps of bioprocesses in 
order to achieve sufficient economic efficiency. The use of organic solvents is frequently used 
either to partly or fully replace water in the reaction medium or as a process aid for downstream 
separation.  
Nowadays, manufacturers are increasingly requested to avoid and substitute solvents with 
hazardous potential. Therefore, the solvent selection must account for potential environmental 
hazards, health and safety problems, in addition to fulfilling the ideal characteristics for application 
in a process.  
For the first time, criteria including Environment, Health and Safety (EHS), as well as the technical 
requirements for reaction and separation have been reviewed, collected and integrated in a single 
organic solvent screening strategy to be used as a guideline for narrowing down the list of solvents 
to test experimentally. Additionally, we have also included a solvent selection guide based on the 
methodology developed in the Innovative Medicines Initiative CHEM21 (IMI CHEM21) project 
and applied specifically to water-immiscible solvents commonly used in bioprocesses. 
 
Keywords: Organic solvents screening, Bioprocesses, Biphasic systems, Downstream processing, 
In situ product removal 
1. Introduction 
There is currently significant interest in the application of biotechnology to chemical manufacture, 
driven in part by the need to replace (or at least minimize) existing fossil feedstocks by renewable 
and sustainable ones. Likewise the chemical industry, and perhaps even more importantly the 
pharmaceutical industry, needs to use ever cleaner processes, with reduced reagent use and waste 
generation. For example, while the E factor is a measure of the amount of waste produced in a 
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process (E factor = kg waste / kg product) (Sheldon, 2017), it is perhaps more useful to examine the 
composition of the waste from a given process. This quickly motivates the need to reduce or replace 
the use of organic solvents, applied primarily for product recovery and purification. For this reason 
several pharmaceutical companies, academic groups and organisations like the ACS Green 
Chemistry Institute (GCI) Pharmaceutical Roundtable have successfully driven an agenda of 
solvent reduction and replacement (Constable et al., 2007; Jessop et al., 2015; Tucker and Faul, 
2016). To a large extent this has been focused on chemical synthetic strategies. However, while this 
serves as a very valuable guidance for today, the range of industrial processes is changing. For 
example, already today several hundred small-molecule pharmaceutical production processes use 
one or more bioprocess steps (Buchholz et al., 2012; Meyer et al., 2013; Woodley, 2017). Indeed as 
industrial interest in cleaner synthesis grows it becomes clear that in the future many more 
bioprocesses will be implemented in industry (Cue and Zhang, 2009; Sheldon and Woodley, 2017). 
Even if fermentation and biocatalysis were to replace a significant fraction of the synthetic reactions 
in the fine chemical and pharmaceutical industry, it remains the case that the products still need to 
be recovered and purified. The downstream separation can include many potential unit operations 
which are dependent upon the product (as well as by-product and substrate) properties. 
Nevertheless, for most biocatalytic reactions and fermentations the product is often toxic (leading to 
an irreversible loss of activity) or inhibitory (leading to a reversible loss of activity) to the 
biocatalyst/microorganism at concentrations much lower than are the minimum required to feed a 
conventional downstream process. This has been the major motivation behind the implementation 
of in situ product removal (ISPR), where inhibitory or toxic products are removed during the 
reaction (either at the site of the reaction, or else in a recycle loop) (Van Hecke et al., 2014; 
Woodley et al., 2008; Zou, 2014). Various methods have been proposed including the use of 
adsorption, pervaporation, perstraction, and crystallization. Extensive reviews have been written on 
this topic and a number of industrial processes use the technology (Carstensen et al., 2012; Dafoe 
and Daugulis, 2014; Freeman et al., 1993; Lye and Woodley, 1999; Stark and von Stockar, 2003; 
Van Hecke et al., 2014; Woodley et al., 2008). Of particular interest is that polymers have been 
used in many ISPR solutions (Phillips et al., 2013) and can potentially be an effective, safer and 
cheaper alternative to the use of organic solvents (Dafoe and Daugulis, 2014). Regardless of the 
type of phase used to recover product it is clear that systematic selection methods are required. On 
this premise we recognized that one of the most used separation methods (aqueous-organic liquid-
liquid extraction) could in particular benefit from a more systematic screening procedure for the 
organic solvent. In this review, for the first time, the criteria to screen for solvents for a bioprocess 
are integrated in a single report, accounting for both the technical, as well as EHS requirements 
which as we have indicated earlier are a prerequisite for industrial implementation. The collection 
of these criteria forms the basis of a screening procedure in particular focused on biphasic systems 
in bioprocesses in order to narrow down the number of solvents to be tested experimentally. In this 
paper in contrast to previous publications (Elgue et al., 2006; Gani, 2006; Zhou et al., 2014), we 
deliberately restrict ourselves to bioprocesses using enzymes or microorganisms, to manufacture 
chemical products. We consider this screening procedure essential for the scientific community 
involved in the early stage development and research of new bioprocesses. Interestingly, this 
rationale is supported by journals such as ChemSusChem (Kemeling, 2012) which has specifically 
asked authors to justify their choice of solvents in submitted manuscripts and if possible to consider 
replacing harmful ones. 
2. Use of organic solvents in bioprocesses 
Whilst the use of water-miscible organic solvents (e.g. ethanol, dimethyl sulfoxide) to help 
solubilize poorly-water soluble organic compounds in single phase biocatalytic systems has been 
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widely reported in the scientific literature, such systems may give only a 10-20% increase in 
substrate and/or product concentration (Sheldon and Pereira, 2017). Additionally, with only a few 
exceptions, such polar solvents strip essential water from the biocatalyst resulting in a loss of 
enzyme stability (Gorman and Dordick, 1992; Kamal et al., 2013; Taher and Al-Zuhair, 2017; Yang 
et al., 2004). On the other hand, essentially water-immiscible organic solvents (containing only 
small amounts of water, at concentrations less than saturation) like n-hexane, t-butyl methyl ether 
etc. can be used for lipase reactions run in a synthetic direction (to avoid hydrolysis)(Bose and 
Keharia, 2013; Carvalho et al., 2015; Devi et al., 2017). In this paper we will focus on the third 
case, where water-immiscible solvents are used in a distinct phase from the aqueous phase, to form 
a two-liquid phase system. 
Here the organic solvents are used for substrate supply, or product removal, in order to overcome 
the low water-solubility of organic compounds and enzyme inhibition by substrate or product. 
Potentially, the solvent may also be used to overcome an unfavourable equilibrium, although this 
requires sufficient driving force to be effective. In this way, the application of two-liquid phase 
systems improves the bioreaction space-time yield (productivity) as well as the product 
concentration fed to the downstream process, and in some cases the selectivity (Boghigian et al., 
2011; Dafoe and Daugulis, 2014; Jung et al., 2013; Mutti and Kroutil, 2012).  
 
2.1 Bioreaction systems 
Several considerations are important in aqueous-organic two-phase biocatalytic systems. The 
organic phase may be deleterious to the biocatalyst in two ways; either by the presence of the 
interface (Martínez-Aragón et al., 2009; Perez-Rodriguez et al., 2003) or by the amount of organic 
solvent dissolved in the aqueous phase which may cause biocatalyst inactivation (Bes et al., 1995; 
Stepankova et al., 2013). Both appear to be important, but in many cases the biocatalyst needs to be 
kept away from the interface.  
Despite the downside described above the introduction of an organic solvent in the bioreaction 
system presents several advantages such as the dissolution of substrates and products at higher 
concentrations in the reactor than would otherwise be achievable. This means that the downstream 
process can be fed at high concentrations, while avoiding inhibitory concentrations of substrate or 
product in the aqueous reaction environment (Hua and Xu, 2011; Lima-Ramos et al., 2014). Easier 
product recovery may also result from the fact that the solvent has a low boiling point, facilitating 
evaporation (Dafoe and Daugulis, 2014). Likewise when designing an in-situ product removal 
(ISPR) process, the mode of contact (direct or indirect) between the biocatalyst and the organic 
phase which removes the product, should be considered (Stark and von Stockar, 2003; Woodley et 
al., 2008). A bioreaction system with direct solvent contact can be characterized by the direct 
exposure of the biocatalyst/cells to the organic solvent [Figure 1 a) and b)]. For a bioreaction 
system with indirect solvent contact [Figure 1 c) and d)] the biocatalyst is not in contact with the 
organic solvent (Stark and von Stockar, 2003; Woodley et al., 2008). 
In Figure 1, two possibilities for running systems with direct contact are presented: a) corresponds 
to the exposure of the biocatalyst to organic solvent within the reactor and b) corresponds to the 
direct contact in a different vessel to the reactor through an external loop. Configuration a) has the 
advantage that both reaction and product removal take place in the same vessel and therefore the 
equipment costs are lower. Configuration b) reduces the contact time between the biocatalyst and 
the organic solvent by introducing an external loop through a separation unit. However, the choice  
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Figure 1 – Three process configurations for a bioreaction in an aqueous-organic two-phase system. Figure adapted from 
Stark and von Stockar, 2003. 
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of solvent has to ensure that the solvent does not deactivate the biocatalyst/microorganism and the 
product has a high enough affinity and solubility. 
Additionally, two configurations for indirect contact are presented in Figure 1: c) corresponds to a 
biphasic reactor with a membrane which separates the two liquid phases and d) corresponds to the 
separation of the biocatalyst/cells from the reactor medium and use of another vessel for the product 
removal. In systems such as c) there is usually a physical barrier such as a membrane which 
prevents the contact of the biocatalyst with the solvent (Stark and von Stockar, 2003; Woodley et 
al., 2008). In the configuration d), the biocatalyst/microorganism is never in direct contact with the 
solvent. The biocatalyst/microorganism is separated from the product and is recycled to the reactor. 
The medium with product dissolved, in its turn, enters a liquid-liquid extraction unit where the 
product is partitioned to the organic solvent and the medium that exits the vessel is recycled to the 
reactor. 
The choice of solvent for a two liquid-phase system with direct contact is more difficult than for an 
indirect contact configuration since it must be compatible with the biocatalyst/microorganism and 
therefore requires a careful study of its toxic effects. 
 
2.2 Downstream processing  
Organic solvents play an important role as separation and purification agents for small-molecule 
chemical products from bioprocesses since they allow easy recovery of organic compounds. The 
use of water as a solvent may present some challenges for downstream processing such as 
separation difficulties, and its high specific heat capacity implies high energy consumption in 
distillation and difficulties rapidly heating and cooling (Adams et al., 2003). Moreover, the 
solubility of many of the most interesting compounds is often very low in water which implies 
excessive amounts of water in order to recover small amounts of product, resulting in high costs. 
When choosing an organic solvent, it should be possible to separate it from the aqueous phase as 
well as recover the desired products from the solvent as shown in Figure 1 e) (Gu, 2000; Koch, 
2015). This should also enable options for recycling the solvent if viable, which could help optimize 
the economic feasibility of a given process, due to lower overall solvent use. Nowadays, the 
recycling of solvents is a common practice in industry. Besides the advantages mentioned above, 
the separation costs for isolating a product from an organic solvent can be much lower when 
compared to an aqueous system.  
The determination of the exact downstream processing conditions depends not only on the nature of 
the product (solid or liquid) but also on the phase in which the product is primarily soluble. For a 
two-liquid phase system (i.e. with two immiscible phases), the operation unit mostly used to purify 
products is liquid-liquid extraction. Concerning energy consumption, liquid-liquid extraction can be 
more attractive since it is a less energy consuming process compared to distillation and gives a 
relatively high efficiency for product recovery (Kurzrock and Weuster-Botz, 2010; Stratakos and 
Koidis, 2016). 
 
3. Overview of criteria to screen solvents for an industrial bioprocess 
 
The list of solvents applicable to industrial processes is extensive and thus, the choice of the 
optimum solvent can be a significant challenge. Hence, at an early stage of process development, it 
is necessary to make a screening of solvents for evaluation of their suitability for the industrial 
process.  
Figure 2 shows a screening procedure which is divided in four evaluation categories: (1) 
environment, health and safety, (2) affinity, recovery and recyclability properties, (3) stability and 
(4)  
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  Figure 2 – Overview of criteria for choosing an organic solvent for a bioprocess divided in tabulated properties in scientific 
literature and experimentally determined properties which are dependent on system and compounds characteristics. 
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application. The screening is also divided between tabulated properties which are already available 1 
in the literature and experimentally determined properties, which are dependent on the 2 
characteristics of the system and have to be experimentally investigated in order to evaluate the its 3 
performance.  4 
The purpose of the screening procedure is to help narrowing the list of possible solvents to be 5 
applied in a bioprocess by evaluating the most important criteria first and eliminating those solvents 6 
which do not fulfill the requirements. The methodology starts by evaluating solvents in terms of 7 
environment, health and safety issues because this is the greatest concern for process development. 8 
Indeed, in order to implement a process it is necessary to fulfill legal and regulatory requirements in 9 
this category. Subsequently, solvents are evaluated in terms of recovery and recyclability properties 10 
and finally the list is shortened by considering those which fulfill the criteria for application in a 11 
given bioprocess. 12 
Ultimately an experimental investigation has to be performed since the solvent is selected according 13 
to the specific system under study. Nevertheless, some of the listed properties such as Log Po/w 14 
provide a direction for the search.  15 
 16 
3.1 Criteria to screen for organic solvents with low hazard environmental, health and safety (EHS) 17 
issues 18 
The adequate selection of solvents is dependent on their suitability for a given application. 19 
However, considerations regarding solvent recovery, solvent release as well as safety at an 20 
industrial site have particular importance. Hence, the primary category to assess is their impact on 21 
environmental, safety and health. It is necessary to take several parameters into account such as 22 
those quantifying the environmental impact (ecotoxicity, flammability, ozone depletion, 23 
incineration potential, etc). Regarding health and safety, some of the parameters are: toxicity & 24 
occupational exposure, auto-ignition temperature, boiling point, flash point, explosivity, reactivity 25 
and vapor pressure; these are particularly important considerations where a bioprocess is run in the 26 
presence of air or oxygen. Solvent selection guides are available, and some institutions and 27 
companies have also made studies to evaluate the hazards of the solvents and suggested alternative 28 
solvents which could substitute the most hazardous ones (Alfonsi et al., 2008; American Chemical 29 
Society (ACS), 2011; Elgue et al., 2006; Henderson et al., 2011; Prat et al., 2016, 2013).  30 
 31 
3.2 Criteria to evaluate the recovery strategies and affinity and stability of an organic solvent 32 
When screening for organic solvents for a particular application in a process there are initially 33 
several considerations to take into account including the affinity, stability and recovery of the 34 
solvent.  35 
The affinity of a given solvent towards a solute is a fundamental property to consider when 36 
choosing a solvent since it determines the viability of the solvent application. Even though this 37 
property is very specific for the process, it is possible to find data bases with information for 38 
specific solute-extractant pairs such as,(Dortmund Data Bank, 2018). In those cases where the 39 
information is not tabulated, the ternary phase behavior can be predicted using thermodynamic 40 
methods such as NRTL, UNIFAC and UNIFAQ. The successful application of these predictable 41 
methods has been widely reported in scientific literature (Abildskov et al., 2001; Brennan et al., 42 
2012; Bruce and Daugulis, 1991; Cheng and Wang, 2010, 2007; Domańska et al., 2015; Ellegaard 43 
et al., 2009; Janseen et al., 1993; Malinowski, 2001, 1999; Malinowski and Daugulis, 1994; 44 
Modarresi et al., 2008; Priebe and Daugulis, 2018; Scilipoti et al., 2014). The reader should also 45 
note that any solvent selected in this way will still need be experimentally tested, not only for 46 
affinity but also for emulsion formation and biocompatibility. 47 
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When choosing a solvent for a bioprocess it is also necessary to take into consideration parameters 48 
such as viscosity, vapor pressure and melting point (Martínez-Aragón et al., 2009; Tzia and 49 
Liadakis, 2003). The values of all these parameters should be low enough to ensure ease of handling 50 
and storage. For example, highly viscous solvents lead to problems effective liquid-liquid mass 51 
transfer. With respect to recovery and recyclability, the boiling point is an important parameter to 52 
consider, especially if the separation is done by distillation (Barwick, 1997). There are several other 53 
criteria to take into consideration as well, such as the ease of drying and azeotrope formation 54 
(Smallwood, 1996; Tzia and Liadakis, 2003). It is relevant to consider that all the factors mentioned 55 
above are very important in order to run a process with a solvent and solvent selection can be a 56 
delicate balance between the different parameters. The properties above are already tabulated and 57 
can be used for screening solvents and reduce the number of solvents to be tested.  58 
The non-precipitation, non-reactivity and chemical stability in the reaction system of the solvent are 59 
also important factors to consider (Tzia and Liadakis, 2003). Likewise the solvent should be stable 60 
and not interact with the reaction solutes (e.g. substrate(s) and product(s)) and cause secondary 61 
reactions. Needless to say, being able to operate the process safely is of paramount importance. 62 
Since most of these properties are dependent on the characteristics of an individual system, 63 
experimental work is necessary in order to assess the suitability of the solvent for the process. 64 
Therefore, these criteria should be evaluated in the end of the screening process to a very short list 65 
of solvents already chosen considering the tabulated properties. 66 
 67 
3.3 Criteria for screening organic solvents as part of a reaction medium in two-liquid phase systems 68 
with free or immobilized biocatalyst/microorganisms  69 
 70 
There are some specific challenges related to the use of solvents in bioreactions. As mentioned 71 
earlier, solvents can be damaging to the biocatalyst, causing degradation and inactivation. For an 72 
enzymatic reaction in a two-liquid phase system, there are some basic principles that can be 73 
followed in order to shorten the list of feasible solvent candidates for initial testing. The solvent 74 
should be as apolar as possible. Nevertheless, it should be noted that for such systems the aqueous-75 
organic interface can also have toxic effects on the biocatalyst. The Log Po/w value is the accepted 76 
parameter for defining the polarity of a solvent. Hence, Log Po/w is useful for describing the 77 
influence of a solvent on enzyme activity. In the scientific literature, high partition coefficients (Log 78 
Po/w > 4) are considered suitable, whilst those with lower values have frequently been found toxic to 79 
biocatalysts (Halling, 1994; Laane et al., 1987; Straathof, 2003).  80 
Solvents with Log Po/w values higher than 4 present a low solubility in water and, practically, the 81 
enzyme dissolved in the aqueous phase does not have contact with the solvent and is able to support 82 
effective product synthesis. On the other hand polar solvents with low Log Po/w values (Log Po/w <2) 83 
are more soluble in water and consequently remove the essential water from the enzyme and disrupt 84 
its conformation with attendant deactivation (Soo et al., 2003). Several authors have reported the 85 
effect of solvents on the performance of enzymes and have shown that enzymes present better 86 
activity in media containing solvents with high Log Po/w  values (Bemquerer et al., 1994; Koutinas 87 
et al., 2018; Lara and Park, 2004; Valivety et al., 1991; Zaks and Klibanov, 1985). 88 
Interestingly, whilst the partition coefficient (Log Po/w) is an important parameter to assess the 89 
suitability for an organic solvent for soluble enzymes, it has also been found useful for immobilized 90 
enzyme systems, although with a more relaxed requirements. For example it has been possible to 91 
achieve good enzyme performance in biphasic systems using immiscible organic solvents with 92 
lower Log Po/w values (range 1-3) (Chaplin et al., 2001; Reslow et al., 1987).  93 
This indicates that the immobilization of the enzyme results in a shift of the Log Po/w-activity curve 94 
as shown in Figure 3 (Laane et al., 1986; Mionetto et al., 1994).Consequently, with immobilized  95 
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 100 
enzymes there is a broadening of the solvent polarity range and an increased number of suitable 101 
solvent options. In these reaction systems, it is believed that the support retains the water molecules 102 
and therefore stabilizes a water layer around the enzyme molecules. The water layer protects the 103 
enzyme molecules and therefore makes them more stable even in organic solvents with lower 104 
partition coefficients.  105 
From the different studies reported, we can conclude that Log Po/w should only be used as a 106 
guideline for screening biocatalyst-compatible solvents. In fact, it is not possible to determine the 107 
suitability of the solvent without performing experiments. Some exceptions to the guideline have 108 
been reported (Cantarella et al., 1993; Geok et al., 2003; Gonçalves et al., 1997).  109 
Furthermore, the characterization of enzyme performance in organic media has often been reported 110 
in an inconsistent manner. So while some authors report the enzyme activity (Mionetto et al., 1994), 111 
or specific activity (Norin et al., 1988), other report the residual activity (Geok et al., 2003; Reslow 112 
et al., 1987) and others again, the reaction conversion or yield (Chaplin et al., 2001; Koutinas et al., 113 
2018; Lara and Park, 2004). These inconsistencies mean that drawing conclusions about the use of 114 
Log Po/w as a parameter for solvent selection is difficult.   115 
For whole-cell biocatalytic systems and fermentation, the relation between cellular activity of 116 
different microorganisms against Log Po/w is also represented by a sigmoidal curve, similar to that 117 
for soluble enzyme (Laane et al., 1987). Several authors (Bassetti and Tramper, 1994; Cruz et al., 118 
2001; Fragnelli et al., 2012; Neumann et al., 2005; Rojas et al., 2004; Silva et al., 2010) have 119 
studied the relationship between cellular activity and Log Po/w. From their results, unsurprisingly it 120 
is possible to conclude that the inflection points between toxic and non-toxic solvents vary 121 
significantly between different microorganisms. Bruce and Daugulis have proposed that the 122 
tolerance of the microorganism is dependent on the characteristics of the cellular membrane (L J 123 
Bruce and Daugulis, 1991).  Whole-cells biocatalysis using organic media has been reviewed and 124 
the authors concluded that the inflection point of the sigmoidal curve is in general above the value 125 
Log Po/w 2 (Heipieper et al., 2007; León et al., 1998). Nonetheless, it is still necessary to perform 126 
experimental screening work for the microorganism of interest. Some authors have engineered the 127 
microorganisms, in order to improve microorganisms tolerance to solvents, and in this way have 128 
Figure 3-Schematic representation of enzymatic activity for both free enzyme and immobilized enzyme on a hydrophilic support 
plotted against Log Po/w of the solvent. Figure adapted from Mionetto et al. 1994. 
10 
 
adapted a specific cell to have tolerance to a specific solvent  (Mukhopadhyay, 2015; Volmer et al., 129 
2014; Zhang et al., 2015).  130 
Regarding bioreactions in  water-organic solvent two-phase systems with immobilized enzymes or 131 
cells, the toxicity of the solvent to the biocatalyst/microorganism is a crucial factor to consider 132 
when screening for organic   solvents. However, the interaction of the solvents with the 133 
immobilization matrix is also an important factor to take into consideration. Immobilization by 134 
adsorption is the simplest method and is characterized by reversible surface interactions between 135 
enzyme/cells and the support material. The interaction forces can be van der Waals forces, ionic and 136 
hydrogen bonding interactions. Since these forces are weak, desorption can occur in the presence of 137 
organic solvents (Brena et al., 2013; Dwevedi, 2016). Synthetic polymer resins can be prone to 138 
swell with certain classes of solvent. On the other hand, porous silica and porous glass have been 139 
shown to be durable and resistant to solvent destruction (Datta et al., 2013). Entrapment, 140 
encapsulation and cross-linking are more resistant methods to solvent interactions. In fact, it has 141 
been reported that these methods are often used to retain catalytic activity in harsh conditions 142 
(temperature and pH extremes and exposure to organic solvents) (Kourkoutas et al., 2004).  143 
 144 
3.4 Criteria for screening organic solvents as extraction agents in downstream processes 145 
Crucial criteria to consider when choosing a solvent as an extraction agent are the solubility of the 146 
target compound to be extracted, affinity towards this compound and the ease of subsequent phase 147 
separation. For instance, when extracting the product with a solvent it is important that the product 148 
is highly soluble in the solvent in order to efficiently recover most of the product from the outlet 149 
stream of the reactor (Kolář et al., 2002). The ease of separation of the solvent from the aqueous 150 
phase is also important, since a complete separation reduces costs. Hence, a large density difference 151 
between the extract phase and raffinate phase (from which the components of interest have been 152 
removed) allows high capacities particularly in liquid-liquid extraction (Gu, 2000; Koch, 2015). 153 
Likewise, the higher the interfacial tension (Gu, 2000; Tzia and Liadakis, 2003), the more readily 154 
coalescence of emulsions will occur and the easier phase separation will be. 155 
In some cases, the direct recovery of a product may not be possible using solvents alone and it is 156 
necessary to use a reactive liquid-liquid extraction which involves a reversible reaction between the 157 
desired chemical compound and the extractant or a host chemical species present in the extractant. 158 
Examples include the removal of carboxylic acids (acetic acid (Mahfud et al., 2008), lactic acid 159 
(Wasewar et al., 2003, 2002), pyruvic acid (Marti et al., 2011), citric acid (Poposka et al., 1998)) by 160 
amines. The extractions involve the complexation reaction of the undissociated acids and amines. 161 
The complexation reaction improves the distribution coefficient. The reaction promotes the 162 
migration of the product to the organic phase. The choice of the solvent is also important when 163 
establishing a reactive liquid-liquid extraction because it has to solvate the amine-acid complex to 164 
avoid its precipitation (Yang et al., 2007). 165 
Another solution, in case direct extraction is not possible, is to manipulate other properties such as 166 
modifying the pH of the output aqueous solution can be useful for separation. An excellent example 167 
of this is the downstream processing for penicillin production. After filtration of the mycelium, the 168 
pH of the broth is adjusted to pH 2-2.5 in order to convert penicillin acid carboxylate into 169 
penicillanic acid. The acidification of the broth increases the partition coefficient of penicillanic 170 
acid (Najafpour, 2007). However, penicillanic acid is unstable in aqueous solution, and this 171 
compound is recovered by an organic solvent, e.g. butyl acetate. The decision regarding the pH 172 
value to be selected should be a compromise between the partition coefficient and product stability 173 
(Wennersten, 2004) and acidification of the broth should be performed in order to minimize product 174 
degradation (Hook, 2006).  175 
 176 
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4. Solvent selection guide for biphasic bioreaction systems 177 
 178 
An overview of the criteria to take into account when selecting a solvent for a specific application 179 
in a process has been described in the preceding sections. In this section, a selection guide for 180 
solvents that are, or could potentially be, used in biphasic biocatalytic/fermentation reactions is 181 
described. The evaluation procedure used to rank the different solvents is similar to the CHEM21 182 
solvent selection guide published by Prat et al. (Prat et al., 2016). 183 
Although there are many beneficial uses for organic solvents in bioprocesses, the use of solvents 184 
presents several environmental, health and safety challenges. When choosing a solvent for the 185 
development of a process it is important to take into account the environmental impact of the 186 
chosen solvent, and the potential safety and health risks associated with handling and using the 187 
given solvent (Clark and Tavener, 2007). Solvents having significant issues should of course be 188 
avoided, if at all possible. There are several solvent selection guides in the scientific literature. 189 
GlaxoSmithKline (GSK) (Alder et al., 2016), the American Chemical Society, Green Chemistry 190 
Institute Pharmaceutical Roundtable (ACS GCIPR) (American Chemical Society (ACS), 2011) and 191 
the solvent guide from CHEM21 (Prat et al., 2016) have presented guides with numerical rankings 192 
and dividing solvents in categories. Pfizer’s (Alfonsi et al., 2008) and Sanofi’s (Prat et al., 2013) 193 
guides present the evaluation results solely in the form of a color code for each solvent, without a 194 
numerical ranking. In addition, the solvent guide from Pfizer presents an overall summarized 195 
evaluation for all solvents, rather than divided in categories.  196 
The survey by Prat et al. (Prat et al., 2014) presents a summary and a comparison of the Health, 197 
Safety and Environment assessments of several solvent guides. The solvent guides considered were 198 
Astra Zeneca’s, ACS GCIPR’s, GSK’s 2011 guide (Henderson et al., 2011), Pfizer’s and Sanofi’s. 199 
The main purpose of this survey was to compare the evaluation criteria across the different solvent 200 
guides and compare the consistency of solvent evaluation across the various guides. 201 
In the present article a new selection guide for solvents commonly used, or of potential use, as 202 
reaction media in biphasic biocatalysis is presented. Some of the included solvents have never been 203 
assessed in previous solvent selection guides due to their specific application in biocatalytic 204 
reaction systems. Other solvent selection guides focus strongly on solvents used in the main for 205 
synthetic organic chemistry applications (Alfonsi et al., 2008; American Chemical Society (ACS), 206 
2011; Henderson et al., 2011; Prat et al., 2016, 2013). An accurate and detailed comparison of all of 207 
the required properties of solvents is not an easy or exact task, since the level and quality of data 208 
available for each solvent is different. This is especially true for the comparison of older solvents 209 
that might have a large amount of data available e.g. substances fully registered under REACH 210 
(ECHA 2016), and newer solvents where very little data is available (at least available in the public 211 
domain). A key feature of the CHEM21 methodology is that it allows a high level ranking of all 212 
solvents where basic physical/safety data and the Globally Harmonized System of Classification 213 
and Labeling of Chemicals (GHS) is known (Prat et al., 2016). The solvents in the guide presented 214 
here have been classified based on the methodology developed within the CHEM21 project. CHEM 215 
21 is a collaborative project between European universities and companies and aims to develop 216 
sustainable biological and chemical alternatives to finite resources and more environmentally 217 
friendly processes. The guide presented here is targeted at process chemists and engineers charged 218 
with operating bioprocesses. In this guide we also provide some examples from the literature which 219 
document the use of the solvents in biocatalytic systems and additionally, the enzymes which have 220 
been used. Other useful data such as solubility in water, Log P and CAS number are also included. 221 
We hope these data will be useful for looking for greener solvents where similar Log P and/or water 222 
solubility values are needed for a successful bioprocess. For large scale processing, solvents which 223 
are solid close to ambient temperature can present specific logistical challenges, so solvents with 224 
12 
 
mp ≥ 10 °C have been marked in the table. The solvents included in the guide were chosen from a 225 
literature survey of biphasic bioreactions, or by looking for newer solvents that may have similar 226 
properties and could be good candidates for this type of transformation. Generally solvents have 227 
been chosen which have 10% or lower solubility in water as a cut off point for a water-immiscible 228 
organic solvent. In certain circumstances, solvents such as tetrahydrofuran and acetonitrile that are 229 
fully water-miscible can form biphasic mixtures with water (high aqueous solute content), but these 230 
were excluded. Data on water-miscible solvents can be found in other published guides (Alfonsi et 231 
al., 2008; American Chemical Society (ACS), 2011; Henderson et al., 2011; Prat et al., 2016, 232 
2013). Solvents that are common to this guide and CHEM21 used the data collated for the 233 
CHEM21 guide (Prat et al., 2016). The data required to assess the new solvents were obtained from 234 
manufacturer’s safety data/material safety data sheets – freely available from suppliers, and from 235 
the European Chemicals Agency, Registered Substances Data (ECHA-RS), 2016. In the case of the 236 
less common solvents and newer solvents, not all of the required data was available or found. In 237 
particular, it was difficult to find values for resistivity (the ability to accumulate a static charge). 238 
Under the methodology solvents likely to build up a static charge (> 108 Ω.m) incrementally add 1 239 
to the safety score. For the additional solvents here, ethers and hydrocarbons were scored as 240 
resistive, and the other solvents as non-resistive. Needless to say, before using any solvents at scale, 241 
a full assessment needs to be made of all operational and safety hazards, including resistivity. 242 
Where air is used for bio oxidation and/or for transformations with living cells, appropriate care 243 
needs to be taken to avoid the formation of an explosive head space if a flammable solvent is used. 244 
Since the processes under consideration here are all biphasic, the production of aqueous waste 245 
streams containing low levels of the organic solvent needs to be considered. Some calculated data 246 
on persistence, bioaccumulation and toxicity has been included in the table. Thus the solvent 247 
selection guide includes an evaluation of persistence in the environment, bioaccumulation in food 248 
chains and toxicity to fish. The persistence, bioaccumulation and toxicity (PBT) evaluation follows 249 
the criteria established by New Chemicals Program (EPA (U.S. Environmental Protection Agency), 250 
2012). The persistence evaluation is performed by investigating the half-life of the compound in 251 
water and air. In relation to the water criteria, if the compound’s half-life is less than 2 months it is 252 
considered recommended (green). If the compound’s half-life is between 2 and 6 months it is 253 
considered problematic (amber). Solvents with a half-life greater than 6 months are considered 254 
hazardous (red). Persistence in air is also evaluated by the half-life; compounds with a half-life 255 
lower or equal to 2 days are considered harmless, those with a half-life greater than 2 days are 256 
considered hazardous (EPA (U.S. Environmental Protection Agency), 2012).  257 
The bioaccumulation criterion corresponds to the bioconcentration factor of a chemical uptake from 258 
the surrounding media by an organism living in that media. If the range of bioconcentration factors 259 
is less than 1000, the solvent is considered recommended for industrial applications (green). 260 
Solvents with bioconcentration factors greater than or equal to 1000 and less than 5000 are 261 
considered to be problematic (amber). Solvents with bioconcentration factors higher than 5000 are 262 
considered hazardous and not advised to be applied in industrial applications (red) (EPA (U.S. 263 
Environmental Protection Agency), 2012). 264 
Toxicity to fish is evaluated by the concentration of the solvent which is chronically toxic to fish, 265 
chronic toxicity value (ChV). Solvents with a ChV greater than 10 mg/L and that do not present any 266 
toxic risk are considered harmless (green). ChV in the range of concentrations 0.1-10 mg/L present 267 
moderate concern and are considered problematic (amber). Solvents with ChV less than 0.1 mg/L 268 
are considered hazardous (red) (EPA (U.S. Environmental Protection Agency), 2012).  269 
Table 2 is the compilation of the assessment of the solvents which are commonly applied, or could 270 
be applied, in bioreactions as a medium. The guide contains a score for each parameter [1 (good) to 271 
10 (bad)] and is color coded for easy reference. The guide is divided into safety, health and 272 
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environmental sections, with an overall recommendation. Scoring is based on physical parameters 273 
such as boiling point, auto ignition temperature etc. and GHS statements. Full details of the 274 
methodology are given in the CHEM21 publication (Prat et al., 2016). For easy comparison in 275 
tabular form, the output is color coded. Green (recommended) indicates that the solvent can be used 276 
with few issues (given normal safe operating procedures are in place to deal with issues such as 277 
flammability, etc). Yellow (problematic) indicates that there may be some issues, but the solvent 278 
should be usable with appropriate mitigation strategies. Red - solvents labeled hazardous or highly 279 
hazardous should be replaced or avoided in developing new processes. In the overall ranking 280 
column, some solvents have a split ranking. This is due to current industrial thinking and practice 281 
that would generally move a solvent into a higher hazard band than that given by the 282 
ranking/scoring process. 283 
For newer solvents that are not fully registered in REACH (thus potentially lacking in some data 284 
sets), the CHEM21 scoring methodology defaults to 5 (problematic/yellow). This is why solvents 285 
such as diethyl succinate and butyl butyrate rank as problematic when compared to very similar 286 
structures like ethyl, tert-butyl or isopropyl acetate, which are fully registered. When full datasets 287 
are available, these materials may become more harmonized in the guide. The REACH process is 288 
generating a lot of data on solvents and the overall picture is constantly changing. Looking into the 289 
future, before using any newer solvent, it would be advised to search for any new data or change in 290 
REACH status that could change the ranking in the table. It is worth noting that especially in the 291 
context of this guide, the methodology scores high boiling solvents (especially > 200 °C, e.g. 292 
diethyl succinate b.p. = 218 °C) poorly in the environmental section since these materials will be 293 
very energy intensive to purify or recover by distillation. 294 
Lastly, the reader should note that the limits of the CHEM 21 selection algorithm define the 295 
assessment of each solvent. There are other solvent selection guides available in the literature and 296 
there are some differences in the classification of the solvents (Prat et al., 2014). Moreover, the 297 
assessment limits might also change with future legislation. In line with this, we are aware that 298 
some solvents which present some toxic and flammable properties (e.g. n-butanol) currently fall 299 
into the category of “Recommended” due to the limits of the evaluation. Moreover, azeotrope 300 
formation was not considered in the selection guide, although in principle it should also be taken 301 
into account when screening for solvents due to separation problems with the recovery of the 302 
solvent or waste water treatment. 303 
  304 
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Table 1 – Compilation of organic solvent selection guides and potential substitution solvents. 305 
High Level Solvent Guide for Biphasic Biocatalysed Reactions 
Solvent, (CAS No), 
mp if ≥ 10 °C 
Solubility in 
water 
g litre-1* 
Log P* 
Precedent for 
use in biphasic 
bioreaction 
Reference 
In 
published 
guides** 
Safety 
Score 
Health 
Score 
Environment 
Score 
PBT 
profile*** 
Overall Ranking 
using CHEM21 
methodology**** 
P B T  
Alcohols 
n-Butanol 
(71-36-3) 63.2 0.79 Dehydrogenase 
(Cremonesi et 
al., 1973) 
P, G, S, 
C21, RT 3 4 3    Recommended 
Isobutanol 
(78-83-1) 70 0.79 Oxidase (Zaks, 1988) 
G, S, C21, 
RT 3 4 3    Recommended 
n-Pentanol 
(71-41-0) 2.03 1.44 Decarboxylase 
(Rosche et al., 
2004) No 3 2 3    Recommended 
n-Heptanol 
(111-70-6) 1.63 2.2 None found 
 No 1 2 5    Recommended 
tert-Amyl alcohol 
(75-85-4) 98 0.77 Oxidase (Zaks, 1988) S 4 2 3    Recommended 
Isoamyl alcohol 
(123-51-3) 21.2 1.35 None found 
 G, C21 3 2 3    Recommended 
1-Octanol 
(111-87-5) 0.5 3.15 Oxygenase 
(Hüsken et al., 
2002) 
No 1 2 5    Recommended 
Benzyl alcohol 
(100-51-6) 40 1.05 None found 
 G, S, C21, RT 1 2 7    Problematic 
1-Dodecanol 
(112-53-8) mp 22 °C 0.0019 5.13 Reductase 
(De Wulf and 
Thonart, 1989) No 1 5 7    Problematic 
1-Decanol 
(112-30-1) 0.021 4.5 Dehydrogenase 
(Pinheiro and 
Cabral, 1992) No 2 2 7    Problematic 
Esters 
Ethyl acetate 
(141-78-6) 87.9 0.68 Dehydrogenase 
(Cremonesi et 
al., 1973) 
P, G, S, 
C21, RT 5 3 3    Recommended 
tert-Butyl acetate 
(540-88-5) 6.7 1.64 ω-Transaminase 
(Meadows et 
al., 2013) G 4 1 3    Recommended 
n-Butyl acetate 
(123-86-4) 5.3 2.3 KRED 
(Ye et al., 
2010) 
G, S, C21, 
RT 4 2 3    Recommended 
Isobutyl acetate 
( 110-19-0) 5.6 2.3 None found 
 S, C21, RT 4 2 3    Recommended 
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n-Propyl acetate 
(109-60-4) 18.7 1.27 None found 
 G 4 2 3    Recommended 
Isopropyl acetate 
(108-21-4) 31.9 1.03 None found 
 P, G, S, C21, RT 4 2 3    Recommended 
Isoamyl acetate 
(123-92-2) 2 2.7 None found 
 C21 3 1 5    Recommended 
n-Butyl butyrate 
(109-21-7) 0.31 2.83 None found  
No 3 5 5    Problematic 
n-Octyl acetate 
(112-14-1) 0.033 3.81 P450 
(Toda et al., 
2012) G 1 5 7    Problematic 
Diethyl succinate 
(123-25-1) 19 1.26 None found 
 G, S, C21 1 5 7     Problematic 
Lauryl acetate 
(112-66-3) 0.00036 5.88 P450 
(Garikipati et 
al., 2009) No 1 5 5    Problematic 
Ethyl decanoate 
(106-33-2) 0.00041 5.71 P450 
(Tan and Day, 
1998) No 1 5 7    Problematic 
Ethyl oleate 
(111-62-6) 6x10
-7 8.51 P450 (Kuhn et al., 2012) No 1 5 7    Problematic 
FAME-Fatty acid 
methyl esters (67762-
38-3) 
0.000023 >6.2 P450 (Schrewe et al., 2014) No Mixture  Problematic 
Bis n-butyl phthalate 
(84-74-2) 
0.011 4.46 KRED (He et al., 
2006) No 1 9 7    Hazardous 
bis(2-ethylhexyl) 
phthalate (117-81-7) 
3x10-6 7.86 P450 (Park et al., 
2007) No 1 9 7    Hazardous 
Tricaprylin 
(538-23-8) 1.5x10
-8 9.2 Plant cell culture (Dutta, 1994) No 1 5 7    Problematic 
Ketones 
Methyl Isobutyl ketone 
(MIBK) (108-10-1) 14.1 1.9 α-Galactosidase 
(Bennett et al., 
1992) 
S,G,C21, 
RT 4 2 3    Recommended 
Cyclohexanone 
(108-94-1) 90 0.86 Imidase 
(Ogawa et al., 
2000) 
G, S, C21, 
RT 3 3 5    R P 
2-Octanone 
(111-13-7) 0.9 2.5 KRED 
(Kohlmann et 
al., 2011) No 3 5 5    Problematic 
2-Undecanone 
(112-12-9) mp 15 °C 0.04 4.1 Oxidation 
(Collins and 
Daugulis, 
1997) 
No 1 5 7    Problematic 
Ethers 
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Dimethyl ether† 
(115-10-6) 335 0.07 KRED 
(Lu et al., 
2004) G 9 2 7    H HH 
Diethyl ether 
(60-29-7) 43.1 1.05 Dehydrogenase 
(Cremonesi et 
al., 1973) 
P, G, S, 
C21, RT 10 3 7    H HH 
Diisopropyl ether 
(108-20-3) 3.1 1.52 
Enoate 
reductase 
(Hall et al., 
2012) 
P, G, S, 
C21, RT 9 3 5    Hazardous 
Dibutyl ether 
(142-96-1) 0.11 3.35 ω-Transaminase 
(Meadows et 
al., 2013) S 5 2 5    Problematic 
2-
Methyltetrahydrofuran 
(96-47-9) 
140 1.1 Benzaldehyde lyase 
(Shanmuganat
han et al., 
2011) 
P, G, S, 
C21, RT 6 3 3    R P 
Cyclopentyl methyl 
ether (CPME) (5614-
37-9) 
3.1 1.59 Benzaldehyde lyase 
(Wiedner et 
al., 2015) 
G, S, C21, 
RT 7 2 5    Problematic 
tert-Butyl methyl ether 
(TBME) (1634-04-4) 41.9 1.23 
Hydroxy nitrile 
Lyase 
(Wiedner et 
al., 2015) 
P, G, S, 
C21, RT 8 3 5    Hazardous 
Ethyl tert-butyl ether 
(ETBE) (637-92-3) 2.37 1.48 None found 
 G, S, C21 7 3 3    Problematic 
tert-Amyl methyl ether  
(TAME) (994-05-8) 10.7 1.55 None found 
 G, C21 6 2 3    Recommended 
Diisoamyl ether 
(544-01-4) 0.028 5.08 Dehydrogenase 
(Hocknull and 
Lilly, 1990) No 4 2 7    Problematic 
Anisole 
(100-66-3) 1.71 2.11 Lipase (Wells, 2010) 
G, S, C21, 
RT 4 1 5    P R 
Halogenated 
Dichloromethane 
(DCM)  
(75-09-2) 
13.2 1.25 Dehydrogenase (Cremonesi et al., 1973) 
P, G, S, 
C21, RT 1 7 7    Hazardous 
Chloroform 
(67-66-3) 
8.7 1.97 Protease (Ogino et al., 
1995) 
P, G, S, 
C21, RT 2 7 5    P HH 
Carbon tetrachloride 
(56-23-5) 
0.65 2.64 Oxidase (Liu et al., 
1996) 
P, G, S, 
C21, RT 2 7 10    H HH 
1,2-Dichloroethane 
(107-06-2) 7.9 1.45 None found 
 P, G , S, C21, RT 4 10 3    H HH 
Chlorobenzene 
(108-90-7) 0.21 2.98 Dehydrogenase 
(Cremonesi, 
1975) 
G, S, C21, 
RT 3 2 7    Problematic 
Methoxyperfluorobutane 
(163702-07-6) 0.01 3.93 Nitrile hydratase 
(Zhu et al., 
2015) 
No 3 6 5    Problematic 
Benzotrifluoride 0.21 3.01 None found  G, RT 5 5 7    Problematic 
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(98-08-8) 
Aromatic hydrocarbons 
Benzene 
(71-43-2) 
1.78 2.1 KRED (Shi et al., 
2008) 
P, G, S, 
C21, RT 6 10 3    H HH 
Toluene 
(108-88-3) 
0.52 2.73 Nitrile hydratase (Cull et al., 
2001) 
P, G, S, 
C21 5 6 3    Problematic 
Xylene 
(1330-20-7) 
0.16 3.15 Oxidase (Aono et al., 
1994) 
P, G, S, 
C21, RT 4 2 5    Problematic 
p-Cymene 
(99-87-6) 0.03 4.1 Lipase 
(Paggiola et 
al., 2014) G, S, C21 4 5 5    Problematic 
Tetralin 
(119-64-2) 0.045 3.78 Reductase 
(Ferrante et 
al., 1995) S 3 6 7    Problematic 
Cumene 
(98-82-8) 0.05 3.55 None found 
 S, G 5 2 7    Problematic 
Aliphatic hydrocarbons 
n-Pentane 
(109-66-0) 0.039 3.45 None found  
P, G, S, 
C21 8 3 7    Hazardous 
n-Hexane 
(110-54-3) 0.01 4 KRED 
(de Gonzalo et 
al., 2007) 
P, G, S, 
C21, RT 8 7 7    Hazardous 
n-Heptane 
(142-82-5) 0.0024 4.5 Dehalogenase (Zou, 2014) 
P, G, S, 
C21, RT 6 2 7    Problematic 
n-Octane 
(111-65-9) 0.0007 5.15 Nitroreductase 
(Meyer et al., 
2006) S, C21 5 2 7    Problematic 
Isooctane 
(540-84-1) 0.0022 4.08 Lipoxygenase 
(Kermasha et 
al., 2002) G, RT 6 2 7    Problematic 
Cyclohexane 
(110-82-7) 0.052 3.44 Esterase (Lee, 1997) 
P, G, S, 
C21, RT 6 3 7    Problematic 
Methylcyclohexane 
(108-87-2) 0.014 3.88 None found 
 P, G, S, C21, RT 6 2 7    Problematic 
Petroleum ether 60/80 
(101316-46-5) As n-hexane 
As n-
hexane KRED 
(Pathan et al., 
2012) G Mixture P H 
Paraffin oil 
(8012-95-1) Insoluble >4 Oxidase 
(Oda et al., 
1996) No Mixture P H 
Decane 
(124-18-5) 
0.000083 5.86 Expandase (Gao and 
Demain, 2001) No 4 2 5    Problematic 
Dodecane 
(112-40-3) 
0.000005 6.98 KRED (Huang et al., 
2005) No 2 2 7    Problematic 
Tetradecane 2.8x10-7 7.2 Dioxygenase (Collins et al., No 2 2 7    Problematic 
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(629-59-4) 1995) 
Hexadecane 
(544-76-3) mp 18 °C 0.000001 8.20 P450 
(Furuhashi, 
1986) No 2 2 7    Problematic 
D-Limonene 
(5989-27-5) 0.006 4.4 Hydratase 
(Savithiry et 
al., 1997) S, C21 4 2 7    Problematic 
Turpentine 
(8006-64-2) 0.002 to 0.35 3 to 6 None found 
 S, C21 4 2 7    Problematic 
 306 
* Data from ECHA database [(ECHA-RS), 2016], literature values (sourced from the Reaxys database, Chemspider) or calculated. Values between 20 and 30 °C. 307 
** Solvent listed in other guides P=Pfizer (Alfonsi et al., 2008), G= GSK (Alder et al., 2016), S= Sanofi (Prat et al., 2013), C21= CHEM21 (Prat et al., 2016), RT= ACS GCI 308 
Pharmaceutical Roundtable (ACS 2011). 309 
Grey shading indicates scoring is not appropriate due to mixtures, or values cannot be calculated for PBT profiler (Environmental Health Analysis Center, 2012) 310 
*** Calculated environmental fate http://www.pbtprofiler.net/ 311 
P = Persistence 312 
B = Bioaccumulation 313 
T = Toxicity to fish 314 
**** Recommendation as an output from the CHEM21 solvent selection methodology (Prat et al., 2016). Where a cell is split, the first column represents the output from the 315 
tool. However, for certain solvents, a second column has been added to reflect current industrial practice and thinking. 316 
† solvent used under pressure, the boiling point of dimethyl ether -24 °C at atmospheric pressure. 317 
  318 
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5. Concluding remarks and future perspectives 319 
This article summarizes water-immiscible solvent applications in bioprocesses and enumerates the 320 
different criteria to take into account in order to select a solvent. The criteria have been compiled 321 
and organized in a screening procedure which helps to narrow down the number of potentially 322 
feasible solvents to be tested experimentally during early stage process development, and to help 323 
guide chemists and engineers towards solvents with the best EHS profiles. The most important 324 
properties that are necessary to consider when screening organic solvents for a process are related to 325 
their environment, health and safety impact, recoverability and stability and their application in the 326 
process, as a reaction medium or applied to downstream processing. 327 
Unfortunately, an ideal solvent is not always available from the shortlist of solvent options, and it is 328 
not always possible to fulfill all of the requirements. For example solvents with high Log P values 329 
are favored for two-liquid phase systems with free, immobilized biocatalysts or whole cells, 330 
whereas these are the very solvents which tend to persist in the environment and score poorly in the 331 
environmental assessment of the solvent guide. More lipophilic solvents also tend to have higher 332 
resistivity and consequently a higher safety score. Therefore, when making the final choice it is 333 
necessary to take a decision about the importance of the evaluation categories and to set strategies 334 
to overcome the constraints of the unfulfilled requirements. These strategies should still establish a 335 
safe and environmentally friendly process with reasonable acceptable costs.  336 
Moreover, sometimes there are also process challenges to overcome such as deactivation of the 337 
biocatalyst in the presence of an organic solvent. This can often be overcome by using an indirect 338 
solvent contact process. In fact, it is also possible to avoid the contact of the biocatalyst with the 339 
solvent by making the extraction outside of the reactor without recirculation of the aqueous phase to 340 
the reactor – Figure 1. 341 
The selection of solvents for application in industrial processes has been changing over the past two 342 
decades. In fact, today there is a tendency both in industry and in research to choose a solvent 343 
taking greater consideration of the environmental impact and also an impact on health, safety and 344 
costs aspects. As an example GlaxoSmithKline Pharmaceuticals’ most frequently used solvents list 345 
has changed towards greener solvents. Solvents such as toluene, dichloromethane and 346 
tetrahydrofuran, which were applied greatly in industry in the 90’s, are presently being replaced. 347 
The three top ranked solvents for industrial application were 2-propanol, ethyl acetate and 348 
methanol. The list of the 10 top ranked solvents includes also ethanol, n-heptane, tetrahydrofuran, 349 
toluene, dichloromethane, acetic acid and acetonitrile (Constable et al., 2007). Moreover, a survey 350 
of solvent usage in development of processes revealed that although there is some room for 351 
improvement on substituting solvents of concern, there is already some reduction of chloroform and 352 
n-hexane applications. Additionally, this investigation shows that the usage of dipolar aprotic 353 
solvents at larger scale (>100 kg scale) is much smaller than in processes at smaller scale (Ashcroft 354 
et al., 2015). Another factor driving industry towards more benign solvents is legislation, especially 355 
Registration and Evaluation of Chemicals (REACH) in the EU which seeks to limit and eventually 356 
remove from use substances with carcinogenic, reprotoxic and mutagenic properties, as well as 357 
materials with a high environmental impact (European Chemicals Agency (ECHA), 2016).  358 
The scientific community has focused research to find greener solvents for bioprocesses and these 359 
efforts are centered on the application of ionic liquids, deep eutectic solvents and supercritical 360 
carbon dioxide (Jessop, 2011). Ionic liquids have been extensively studied by the scientific 361 
community as possible reaction media for biocatalysis. Ionic liquids are mixtures of cations and 362 
anions which do not pack well and therefore, these mixtures are in liquid phase at room 363 
temperature. Several enzymes have been tested having ionic liquids or a mixture of ionic liquid and 364 
water as reaction media. From the scientific literature, it is possible to conclude that in ionic liquids 365 
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several enzymes present good stereoselectivity, reaction yield, activity and stability (Lou et al., 366 
2005; Lozano et al., 2001). For example, Lozano and coworkers have studied α-chymotrypsin and 367 
verified an increase of its half-life and the conversion of the substrate when compared to 1-propanol 368 
(Lozano et al., 2001). The implementation of ionic liquids in industrial processes will require more 369 
information regarding their toxicity, ecotoxicity and their life cycle impact. Moreover the 370 
ecotoxicity of the ionic liquid seems to be related to the branching of the alkyl chain and to 371 
hydrophobicity of the cation (Docherty and Kulpa, Jr., 2005). Some of the ionic liquids have EC50 372 
(acute toxicity value) values much lower than for example toluene, which means they are more 373 
ecotoxic. Another aspect to consider when evaluating the environmental impact of ionic liquids is 374 
the environmental impact of their synthesis. The synthesis of an ionic liquid sometimes requires the 375 
use of harmful organic solvents (Deetlefs and Seddon, 2010; Zhang et al., 2008). There have also 376 
been efforts to decrease the toxicity of ionic liquids. In fact the third generation of ionic liquids has 377 
been considered cheaper, sustainable, non-toxic and biodegradable (Domínguez de María and 378 
Maugeri, 2011; Fukaya et al., 2007). 379 
Supercritical carbon dioxide (scCO2) is also considered a sustainable solvent since it is non-380 
flammable, has low toxicity, is broadly inert limiting unwanted reactions, and is present in 381 
abundance as a by-product of industrial processes like fermentation and thermal cracking. Although 382 
scCO2 presents several advantages at safety and process level, it has also some associated 383 
disadvantages. Some organic substrates have poor solubility in scCO2, requiring the use of a co-384 
solvent. A process which uses supercritical carbon dioxide requires high pressure equipment and 385 
therefore it is necessary to consider carefully the safety aspects. Furthermore, another constraint of 386 
the application of scCO2 in a process is the cost of operation and equipment capital cost which is 387 
much higher compared to a standard organic solvent since the process has to operate at high 388 
pressure (Beckman, 2004). Concerning application in bioprocesses, studies have demonstrated that 389 
scCO2 can improve reaction rates and control reaction selectivity by pressure. Many enzymes have 390 
been demonstrated to have a high performance in scCO2 compared to organic solvents. Examples 391 
include hydrolases, oxygenases and dehydrogenases, and have been reviewed by Wimmer and 392 
Zarevúcka, 2010. In addition, lipases seem to have been extensively studied and reported in the 393 
scientific literature (Khosravi-Darani and Mozafari, 2009). However, the enzyme is not always 394 
stable in a biphasic CO2/H2O system due to the dissolution of CO2 in water which causes the 395 
formation of H2CO3. Consequently, pH will decrease (2.85) and the enzyme can be deactivated. In 396 
addition, carbon dioxide is a Lewis acid and reacts with strong bases and nucleophiles (Beckman, 397 
2004). Therefore, it is necessary to take this fact into account when considering the application of 398 
scCO2 in processes in which these compounds are substrates or products.  399 
The solvent for a process can be chosen from several categories of solvents: water, organic solvents, 400 
ionic liquids and supercritical fluids. Jessop has consulted top academic experts in green solvents 401 
about which solvents they would choose for industrial application, and the choice fell on water, 402 
supercritical carbon dioxide and carefully-selected organic solvents (Jessop, 2011).  403 
In conclusion, the choice of a solvent for a bioprocess should comprise a balance between the 404 
effects on the environment, effects on human health, safety hazards, biocatalyst/microorganism 405 
activity, solubility and selectivity of substrates and/or products and recovery. This balance is 406 
important because it is not always possible to find a solvent which fully covers all these criteria. 407 
Problems regarding the impact of a solvent on Environment, Health and Safety are increasingly 408 
being taken into account in process development when considering the application of a solvent as a 409 
reaction medium or as part of downstream processing in new processes. Moreover, in recent years, 410 
there has been more focus to substitute the hazardous solvents in already running processes.  411 
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